BCL2 and leukemia: LAGADINOU et al. discovered that AML cells enriched with low levels of ROS from leukemia stem cells (LSCs) exhibited elevated expression of B-cell lymphocytoma-2 (Bcl-2), an antiapoptotic protein involved in mitochondrial regulation.